Cargando…
Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis
Development of novel anti-tuberculosis combination regimens that increase efficacy and reduce treatment timelines will improve patient compliance, limit side-effects, reduce costs, and enhance cure rates. Such advancements would significantly improve the global TB burden and reduce drug resistance a...
Autores principales: | Hasenoehrl, Erik J., Wiggins, Thomas J., Berney, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831573/ https://www.ncbi.nlm.nih.gov/pubmed/33505923 http://dx.doi.org/10.3389/fcimb.2020.611683 |
Ejemplares similares
-
Failing upwards: Genetics-based strategies to improve antibiotic discovery and efficacy in Mycobacterium tuberculosis
por: Tomasi, Francesca G., et al.
Publicado: (2022) -
Understanding and Exploiting the Effect of Tuberculosis Antimicrobials on Host Mitochondrial Function and Bioenergetics
por: Cahill, Christina, et al.
Publicado: (2020) -
Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
por: Greenstein, Talia, et al.
Publicado: (2023) -
Editorial: Cellular and Molecular Mechanisms of Mycobacterium tuberculosis Virulence
por: Sun, Jianjun, et al.
Publicado: (2019) -
Unraveling the mechanisms of intrinsic drug resistance in Mycobacterium tuberculosis
por: Poulton, Nicholas C., et al.
Publicado: (2022)